21 – 30 of 330
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool
(
- Contribution to journal › Article
-
Mark
Screening for prostate cancer : evidence, ongoing trials, policies and knowledge gaps
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Drug use disorder and risk of incident and fatal prostate cancer among Swedish men : a nationwide epidemiological study
(
- Contribution to journal › Article
-
Mark
Isolation of Circulating Tumor Cells with Acoustophoresis : Towards a biomarker assay for prostate cancer
2022)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Aspects of PET-CT in prostate cancer. Protocol optimization, diagnostic accuracy, and dosimetry.
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
(
- Contribution to journal › Article
-
Mark
PSA : role in screening and monitoring patients with prostate cancer
2022) p.131-172(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
(
- Contribution to journal › Article
-
Mark
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
(
- Contribution to journal › Article
-
Mark
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
(
- Contribution to journal › Article